Advanced Life Sciences Holdings Company Profile - Mar 13, 2011 by WrightReports

VIEWS: 2 PAGES: 9

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Advanced Life Sciences Holdings, Inc.
                                                                                      440 Wheelers Farms Road
                                                                                      Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in U.S. Dollars

                                 Wright Quality Rating:LLNN                                Key Data

   Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company focused on         Ticker:
   the discovery, development and commercialization of drugs in the areas of infectious    ADLS
   disease, oncology and respiratory disease. The Company has assembled a pipeline of
   clinical and preclinical product candidates. The Company has a worldwide license        2009 Sales:
   (excluding Japan) from Abbott Laboratories (Abbott) to develop and commercialize
                                                                                           2,793,191
   cethromycin, once-a-day antibiotic for the treatment of respiratory tract infections.
                       Stock Chart                                Officers
                                                                                           Major Industry:
                                                         Chairman & Chief Executive
                                                                                           Drugs, Cosmetics & Health
                                                             Dr. Michael T. Flavin
                                                                                           Care
                                                          President & Chief Financial
                                                                    Officer                Sub Industry:
                                                                 John L. Flavin            Diversified Drugs,
                                                                                           Cosmetics, & Health Care

                                                                                           Country:
                                                                                           United States

                                                                                           Currency:
                                                                                           U.S. Dollars

                                                                                           Fiscal Year Ends:
                                                                                           December

                                                                                           Employees
                                                                                           19
             Stock Price (3/4/2011): 0.02
              Recent stock performance                                                     Exchanges:
                  1 Week      -15.2%                                                       OTC
                  4 Weeks     -16.0%
                  13 Weeks    -32.8%                                                       Share Type:
                  52 Weeks    -89.6%                                                       Common
                       Earnings / Dividends (as of 9/30/2010)
             
								
To top